Tag Archives: Europe

October Sees 'Tsunami of Lobbying and Legislation' in Europe

April might be – as T S Eliot suggested – the cruellest month, but for pharmaceuticals in Europe, this October is certainly a contender to win an award as the busiest month. When the penultimate day of the month offered a breakthrough agreement to start discussions between European Union ambassadors and the European Parliament on […]
Posted in Europe, Global, Guest Blog, healthcare, Regulatory, Strategy | Also tagged , , , , , | Leave a comment

EU Tense as Crunch-Time for Counterfeits Approaches

By Reflector, Pharm Exec’s Brussels correspondent. Tensions are rising in Europe’s pharmaceutical sector as crunch-time approaches for the legislation to combat counterfeits. By this time next year, the European Commission is due to have decided on the mechanisms required to put into effect the European Union’s hugely complex new rules to keep falsified medicines out […]
Posted in Europe, Global, Guest Blog | Also tagged , , , , , | Leave a comment

FT Healthcare Conference: Society as Stakeholder

Speakers at the 2nd annual Financial Times US Healthcare and Life Sciences conference in New York last week discussed the cost of health, and the implications of an increasingly vocal and influential stakeholder group: the local populace. After opening remarks from Andrew Jack, FT’s prolific pharmaceuticals correspondent, Pfizer CEO Ian Read took the stage at […]
Posted in Europe, Events, Global, healthcare, leadership, Market Access, Orphan Drugs, People, pricing, R&D, Regulatory, Strategy, Technology | Also tagged , , , , , , , , , , , , , , , , | Leave a comment

European Clinical Trials Policy Gets Caught Up in Politics

The latest stage of Europe’s attempt to update its clinical trials rules offered a mildly distressing spectacle of the intrusion of politics into policy, writes Peter O’ Donnell. It is inevitable, of course, that legislation should be colored by politics in any democracy, since legislators, being elected, are by nature political animals. But in an […]
Posted in Guest Blog | Also tagged , , | 1 Comment

First 'Real' European Patent Imminent

It’s exciting times for patents in Europe. Not everyone’s excitement is pleasurable, but there’s certainly plenty going on, writes Reflector, Pharm Exec‘s EU correspondent. Much of the excitement is linked to the imminent advent of Europe’s first real European patent. After decades of failed attempts, by the beginning of 2014 the European Union will finally […]
Posted in Europe, Guest Blog, IP | Also tagged , , , , | 1 Comment
  • Categories

  • Meta